Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple Sclerosis

Clinical trial NCT03025269 · COMPLETED

Trial details

NCT number: NCT03025269
Sponsor: University at Buffalo
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2017-11-15
Primary completion: 2022-01-08
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.